Data on hyperkalemia frequency among chronic kidney disease (CKD) patients receiving renin-angiotensin aldosterone system inhibitors (RAASis) and its impact on subsequent RAASi treatment are limited.

Figshare2019-03-07 更新10

Rapid Ventricular Tachycardias Associated with Cilostazol Use

药物不良反应监测

心血管事件风险

A 92-year-old woman with normal systolic function had recently begun using the newly approved phosphodiesterase III inhibitor cilostazol when she was admitted with lower-extremity pain. Cilostazol is

PubMed Central30

Overall summary of adverse events (treated set).

药物不良反应监测

临床试验安全性分析

aPatients were randomised 2:2:1 to the tiotropium Respimat 5 μg, tiotropium Respimat 2.5 μg and placebo Respimat groups, respectively. bAs determined by the investigator. cElevation of aspartate amino

NIAID Data Ecosystem20

Reasons for Drug Discontinuation in Stages 1 and 2.

资源简介：

相关数据集